Taiwan FDA registration 20b6c1153d0d5a0d1766d61494a6ad2a
Bell Amphetamine test reagent
TW: 貝爾安非他命檢驗試劑
Taiwan·Risk Class 2·SYNTRON BIORESEARCH INC.,·Registered Jan 23, 2006 – Jan 23, 2011CancelledRegistration details
- Analysis ID
- 20b6c1153d0d5a0d1766d61494a6ad2a
- Customs Code
- DHA00601592504
Company information
- Manufacturer
- SYNTRON BIORESEARCH INC.,
- Manufacturer Country
- United States
- Authorized Representative
- Taiwan Bell Pharmaceutical Co., Ltd
Product details
- Intended Use
- Rapid and qualitative immunoassays are used to measure anandamide and its substitutes in urine at 500 ng/ml or above.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.3610 Methamphetamine testing system
- Import Information
- import
Dates and status
- Registration Date
- Jan 23, 2006
- Expiry Date
- Jan 23, 2011
- Cancellation Date
- Nov 02, 2006
Cancellation information
- Status
- Logged out
- Reason
- 註銷藥商許可執照
About this record
Access comprehensive regulatory information for Bell Amphetamine test reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 20b6c1153d0d5a0d1766d61494a6ad2a and manufactured by SYNTRON BIORESEARCH INC.,. The authorized representative in Taiwan is Taiwan Bell Pharmaceutical Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices